Obese patients with breast cancer who are receiving anthracyclines and/or trastuzumab have an increased risk of ... This week's Round-up features two interesting studies focusing on women's health, an interesting cardio-oncology paper, ... Research published in JACC CardioOncology suggests that neurohormonal therapies are associated with higher left ... Physical exercise may be a promising and effective treatment for patients with cancer during and after chemotherapy in ... Ibrutinib administration was associated with a number of severe cardiac events, results from a new analysis suggest.
... Many patients with cancer undergoing treatment incur a risk of cardiotoxicity, and these patients are not being made ... This week’s edition of the Cardio Round-up includes a warning about skipping breakfast, an FDA approval on the ... Here are the top stories covered by DocWire News this week in the Hematology/Oncology section. This week the U.S. Food ... A new paper in Cardiovascular Research looks at genomic predisposition to oncology-drug-induced cardiotoxicity, which ... New research published in JAMA Oncology suggests that daunorubicin is associated with lower incidence of cardiomyopathy ...